Nature Genetics Advance Online Publication Meta-analysis of 375,000 Individuals Identifies 38 Susceptibility Loci for Migraine
Nature Genetics Advance Online Publication Meta-analysis of 375,000 Individuals Identifies 38 Susceptibility Loci for Migraine
复制标题
DOI:
--
复制
发表时间:
--
期刊:
影响因子:
--
通讯作者:
P. Gormley;V. Anttila;V. Anttila;B. Winsvold;B. Winsvold;P. Palta;T. Esko;T. Esko;T. Esko;T. Pers;Kai-How Farh;Kai-How Farh;Kai-How Farh;E. Cuenca-León;M. Muona;N. Furlotte;Tobias Kurth;Tobias Kurth;A. Ingason;George Mcmahon;L. Ligthart;G. Terwindt;M. Kallela;T. Freilinger;T. Freilinger;C. Ran;S. Gordon;A. Stam;S. Steinberg;G. Borck;M. Koiranen;L. Quaye;H. Adams;T. Lehtimäki;Antti-Pekka Sarin;J. Wedenoja;D. Hinds;Julie E. Buring;Julie E. Buring;M. Schürks;P. Ridker;P. Ridker;M. Hrafnsdottir;H. Stefánsson;S. Ring;J. Hottenga;B. Penninx;M. Färkkilä;V. Artto;M. Kaunisto;Salli Vepsäläinen;R. Malik;A. Heath;P. Madden;N. Martin;G. Montgomery;M. Kurki;M. Kals;R. Mägi;K. Pärn;E. Hämäläinen;Hailiang Huang;Hailiang Huang;Andrea Byrnes;Andrea Byrnes;L. Franke;Jie Huang;E. Stergiakouli;Phil H. Lee;Phil H. Lee;C. Sandor;C. Webber;Zameel M. Cader;Zameel M. Cader;B. Müller-Myhsok;S. Schreiber;T. Meitinger;Jenny Casey Eriksson;J. Eriksson;V. Salomaa;K. Heikkilä;E. Loehrer;E. Loehrer;A. Uitterlinden;A. Hofman;C. Duijn;L. Cherkas;L. Pedersen;A. Stubhaug;A. Stubhaug;Christopher S Nielsen;C. Nielsen;M. Männikkö;E. Mihailov;L. Milani;Hartmut Göbel;A. Esserlind;A. F. Christensen;T. Hansen;T. Werge;T. Werge;T. Werge;Jaakko Kaprio;Jaakko Kaprio;A. Aromaa;Olli T. Raitakari;Olli T. Raitakari;M. Ikram;T. Spector;M. Järvelin;A. Metspalu;C. Kubisch;D. Strachan;M. Ferrari;A. C. Belin;M. Dichgans;M. Wessman;A. M. Maagdenberg;J. Zwart;J. Zwart;D. Boomsma;G. D. Smith;K. Stefánsson;K. Stefánsson;N. Eriksson;M. J. Daly;M. J. Daly;B. Neale;B. Neale;Jes Olesen;D. Chasman;D. Chasman;D. Nyholt;A. Palotie
中科院分区:
文献类型:
--
作者:
P. Gormley;V. Anttila;V. Anttila;B. Winsvold;B. Winsvold;P. Palta;T. Esko;T. Esko;T. Esko;T. Pers;Kai-How Farh;Kai-How Farh;Kai-How Farh;E. Cuenca-León;M. Muona;N. Furlotte;Tobias Kurth;Tobias Kurth;A. Ingason;George Mcmahon;L. Ligthart;G. Terwindt;M. Kallela;T. Freilinger;T. Freilinger;C. Ran;S. Gordon;A. Stam;S. Steinberg;G. Borck;M. Koiranen;L. Quaye;H. Adams;T. Lehtimäki;Antti-Pekka Sarin;J. Wedenoja;D. Hinds;Julie E. Buring;Julie E. Buring;M. Schürks;P. Ridker;P. Ridker;M. Hrafnsdottir;H. Stefánsson;S. Ring;J. Hottenga;B. Penninx;M. Färkkilä;V. Artto;M. Kaunisto;Salli Vepsäläinen;R. Malik;A. Heath;P. Madden;N. Martin;G. Montgomery;M. Kurki;M. Kals;R. Mägi;K. Pärn;E. Hämäläinen;Hailiang Huang;Hailiang Huang;Andrea Byrnes;Andrea Byrnes;L. Franke;Jie Huang;E. Stergiakouli;Phil H. Lee;Phil H. Lee;C. Sandor;C. Webber;Zameel M. Cader;Zameel M. Cader;B. Müller-Myhsok;S. Schreiber;T. Meitinger;Jenny Casey Eriksson;J. Eriksson;V. Salomaa;K. Heikkilä;E. Loehrer;E. Loehrer;A. Uitterlinden;A. Hofman;C. Duijn;L. Cherkas;L. Pedersen;A. Stubhaug;A. Stubhaug;Christopher S Nielsen;C. Nielsen;M. Männikkö;E. Mihailov;L. Milani;Hartmut Göbel;A. Esserlind;A. F. Christensen;T. Hansen;T. Werge;T. Werge;T. Werge;Jaakko Kaprio;Jaakko Kaprio;A. Aromaa;Olli T. Raitakari;Olli T. Raitakari;M. Ikram;T. Spector;M. Järvelin;A. Metspalu;C. Kubisch;D. Strachan;M. Ferrari;A. C. Belin;M. Dichgans;M. Wessman;A. M. Maagdenberg;J. Zwart;J. Zwart;D. Boomsma;G. D. Smith;K. Stefánsson;K. Stefánsson;N. Eriksson;M. J. Daly;M. J. Daly;B. Neale;B. Neale;Jes Olesen;D. Chasman;D. Chasman;D. Nyholt;A. Palotie
A r t i c l e s vascular changes representing downstream effects that are not themselves causative of migraine 4,5. However, genetic evidence favoring one theory over the other is lacking. At the phenotype level, migraine is defined by diagnostic criteria from the International Headache Society 6. There are two prevalent subforms: migraine without aura, which is characterized by recurrent attacks of moderate or severe headache associated with nausea or hypersensitivity to light and Migraine is a debilitating neurological disorder affecting around one in seven people worldwide, but its molecular mechanisms remain poorly understood. There is some debate about whether migraine is a disease of vascular dysfunction or a result of neuronal dysfunction with secondary vascular changes. Genome-wide association (GWA) studies have thus far identified 3 independent loci associated with migraine. To identify new susceptibility loci, we carried out a genetic study of migraine on 59,674 affected subjects and 36,078 controls from 22 GWA studies. We identified 44 independent single-nucleotide polymorphisms (SNPs) significantly associated with migraine risk (P < 5 × 0 −8) that mapped to 38 distinct genomic loci, including 28 loci not previously reported and a locus that to our knowledge is the first to be identified on chromosome X. In subsequent computational analyses, the identified loci showed enrichment for genes expressed in vascular and smooth muscle tissues, consistent with a predominant theory of migraine that highlights vascular etiologies. Migraine is the third most common disease worldwide, with a lifetime prevalence of 15–20%, affecting up to 1 billion people across the globe 1,2. It ranks as the seventh most disabling disease worldwide (and the most disabling neurological disease) in terms of years of life lost to disability 1 , and it is the third most costly neurological disorder, after dementia and stroke 3. There is debate about whether migraine is a disease of vascular dysfunction or of neuronal dysfunction with